Editorial office of Journal of Cancer Metastasis and Treatment is delighted to announce that JCMT has adopted MESAs, a brand-new online submission & review system from 21 March 2019, to provide superior publishing experience for our users.
MESAs is an easy-to-use online smart manuscript processing system, developed thanks to the concerted efforts of over 40 members of the professional team of OAE publishing Inc., after 14 months of elaborate research and design. The system follows international publishing standards specified by Committee on Publication Ethics (COPE), Directory of Open Access Journals (DOAJ), World Association of Medical Editors (WAME) and International Committee of Medical Journal Editors (ICMJE). It provides convenient and pragmatic services for authors, reviewers and editors, which makes standardized and efficient publishing management a reality.
From this date onwards, all manuscripts are to be submitted to MESAs at https://oaemesas.com/jcmt/. By logging into MESAs, authors can easily submit and track the status of manuscripts in real time, peer reviewers can download articles and upload review comments, and editors can manage the whole process of scholarly publishing. Previously submitted articles can still be tracked in ScholarOne system at https://mc03.manuscriptcentral.com/jcmt before 30 Aug 2019. After then the ScholarOne system shall be officially closed.
We would like to take this opportunity to express our gratitude to editorial board members and readers who have helped us improve. There's no rest of bettering. Should you have any suggestions about or problems with MESAs, welcome to contact us at email@example.com.